Connect with us

Health

COVID vaccine nasal spray shows strong immune response in study: ‘Could be a game changer’

Published

on

COVID vaccine nasal spray shows strong immune response in study: ‘Could be a game changer’

A brand new examine has proven promising outcomes for a nasal COVID-19 vaccine, in response to researchers on the Institute of Virology at Freie Universität Berlin in Germany. 

When two doses of the reside nasal vaccine have been administered to hamsters, the animals confirmed a stronger immune response in comparison with their response to 2 doses of the vaccines which are presently accessible.

The examine was revealed within the journal Nature Microbiology on Monday.

COVID VACCINE FATIGUE: STUDY EXPLORES WHY MANY ARE REFUSING BOOSTER SHOTS

Advertisement

The lead creator of the examine informed Fox Information Digital this week, “We discover {that a} reside attenuated vaccine prevents virus replication — this could possibly be a recreation changer in controlling SARS-CoV-2 transmission.”

Nasal vaccines not but accessible in US

At the moment, there are 4 authorized COVID vaccines within the U.S. — all of that are administered by way of injection into the muscle, per the Facilities for Illness Management and Prevention (CDC).

The Pfizer-BioNTech and Moderna vaccines are each mRNA vaccines, which use mRNA (messenger RNA) to set off cells to supply a viral protein. 

This prompts the immune system to create antibodies.

A brand new examine has proven promising outcomes for a nasal COVID-19 vaccine in Germany, in response to researchers on the Institute of Virology at Freie Universität Berlin. (A fictional prototype is pictured.) (iStock)

Advertisement

Johnson & Johnson’s Janssen is a viral vector vaccine, which delivers DNA “directions” to the physique’s cells by way of a distinct, non-harmful virus.

The Novavax vaccine is a protein subunit vaccine, which makes use of some proteins of the virus that causes COVID-19 — often called the “spike protein” — to “practice” the immune system to behave in opposition to future spike proteins.

“The purpose is to create a barrier to cease virus unfold.”

The nasal COVID vaccine that is being examined is a live-attenuated vaccine, which suggests it comprises a reside however weaker type of the coronavirus. 

It really works by stopping the virus within the higher airway earlier than it could journey additional into the physique.

Advertisement

Examine targeted on Syrian hamsters

The researchers used Syrian hamsters for his or her vaccine testing. 

The examine’s lead creator, Dr. Jakob Trimpert, head of diagnostics on the Institute of Virology at Freie Universität Berlin in Germany, mentioned hamsters are the “prime non-transgenic [not genetically modified] small animal mannequin” for COVID-19 analysis.

AI TESTING OF BRAIN TUMORS CAN DETECT GENETIC CANCER MARKERS IN LESS THAN 90 SECONDS, STUDY FINDS

“These animals have the good benefit of being naturally inclined to SARS-CoV-2 an infection, together with pure unfold between hamsters,” he defined to Fox Information Digital. 

“The an infection of Syrian hamsters resembles many key options of average human COVID-19 — this makes the hamster a super mannequin to examine COVID-19 vaccines and therapies.”

Advertisement

Nasal vaccines present ‘superior safety’

The nasal vaccines have important benefits over the injectable vaccines which are presently accessible, Dr. Trimpert mentioned. 

“An intra-nasally utilized live-attenuated vaccine supplies superior safety in opposition to SARS-CoV-2 an infection in comparison with intramuscularly utilized vaccines,” he informed Fox Information Digital.

Whereas he mentioned presently marketed vaccines do an excellent job of stopping extreme sickness from COVID, Dr. Trimpert identified that they do not forestall the an infection, average sickness or unfold.

“We discover {that a} reside attenuated vaccine prevents virus replication” — so “this could possibly be a recreation changer in controlling SARS-CoV-2 transmission.”

Nasal vaccines have significant advantages over the injectable vaccines that are currently available, said the study's lead author.

Nasal vaccines have important benefits over the injectable vaccines which are presently accessible, mentioned the examine’s lead creator. (iStock)

The principle advantage of a nasal vaccine is that immunity is activated proper the place it’s wanted, Dr. Trimpert mentioned.

Advertisement

“It’s the induction of native immunity on the website of pure an infection that could possibly be a game-changer right here,” he mentioned. 

“Judging from our outcomes, this has appreciable impression and vastly reduces the danger of an infection.”

Physician sees nasal vaccines as ‘a superb thought’

Dr. Marc Siegel, professor of medication at NYU Langone Medical Heart and a Fox Information medical contributor, mentioned he finds this new analysis promising. He was not concerned within the examine.

“The purpose is essential: to create a barrier to cease virus unfold,” he informed Fox Information Digital.

Today, there are four approved COVID vaccines in the U.S., all of which are administered via injection into the muscle, according to the Centers for Disease Control and Prevention (CDC).

At the moment, there are 4 authorized COVID vaccines within the U.S., all of that are administered by way of injection into the muscle, in response to the Facilities for Illness Management and Prevention (CDC). (Nicolas Maeterlinck/Belgia/AFP by way of Getty Photos)

“This includes IGA antibodies and works on the degree of the mucus membranes.” 

Advertisement

IGA, or Immunoglobulin A, is an antibody that performs an vital half within the immune perform of mucous membranes.

The mucous membrane, or the nasal mucosa, is the tissue that strains the nasal cavity.

COVID VACCINES ARE NOT NEEDED FOR HEALTHY KIDS AND TEENS, SAYS WORLD HEALTH ORGANIZATION

The nasal vaccine could possibly be standalone or might work together with different vaccines, mentioned Dr. Siegel. 

“If it’s efficient and human trials of the German vaccine are ongoing, it will likely be an enormous step ahead,” he mentioned.

Advertisement

Dr. Norman B. Gaylis, who has handled over 1,000 sufferers at his Lengthy Haul COVID Clinic in Aventura, Florida, additionally reviewed the findings.

“I consider it’s a superb thought to create a vaccine that may construct immunity within the nasal mucosa,” he informed Fox Information Digital. 

"Research has shown that COVID and other viruses often enter through the nose, and travel up the olfactory nerve … and then into the brain," a doctor explained.

“Analysis has proven that COVID and different viruses typically enter by means of the nostril, and journey up the olfactory nerve … after which into the mind,” a physician defined. (iStock)

“Analysis has proven that COVID and different viruses typically enter by means of the nostril, and journey up the olfactory nerve … after which into the mind,” he defined.

Creating a nasal vaccine might assist forestall viruses from gaining quick access to the mind, mentioned Dr. Gaylis. 

“That is vital as a result of many ‘lengthy COVID’ sufferers are reporting mind injury from the virus,” he added.

Advertisement

MOST ‘LONG COVID’ SYMPTOMS AFTER MILD CASE OF VIRUS RESOLVE IN ABOUT A YEAR: NEW STUDY

Moreover, a nasal vaccine would offer a useful various for sufferers who’ve a worry of needles, permitting them to get protected and not using a jab, mentioned the physician.

Different nasal vaccines in improvement

As of July 2022, there have been at the very least 12 nasal COVID vaccines in scientific improvement, in response to Science Immunology.

The biotechnology firm Codagenix introduced in October 2022 that it had entered the Section 3 scientific trial for CoviLiv, its intranasal COVID-19 vaccine that’s supposed for wholesome adults.

As of July 2022, there have been at the very least 12 nasal COVID vaccines in improvement.

Advertisement

The Icahn College of Drugs at Mount Sinai in New York Metropolis has launched a Section 1 examine evaluating a brand new egg-based COVID vaccine, referred to as NDV-HXP-S, which will be administered nasally or by way of muscular injection.

In June 2022, the Nationwide Institute of Allergy and Infectious Illnesses revealed a examine illustrating the effectiveness of nasal COVID vaccines in hamsters. 

This was adopted by one other examine in September 2022, which confirmed that nasal vaccines produced a robust immune response in rhesus monkeys.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Each China and India have authorized nasal COVID vaccines for people, as reported within the journal Nature in September 2022.

Advertisement

Those that are contemplating a brand new vaccine ought to seek the advice of with a physician to make sure that it’s proper for them.

Iran and Russia have additionally authorized nasal types of the vaccine, although there may be restricted knowledge accessible about their effectiveness.

Extra analysis is required

The German analysis crew plans to proceed investigating the effectiveness of its vaccines and appears ahead to shifting into scientific trials.

The study focused on Syrian hamsters, finding that the nasal vaccine provided significant protection against the virus. The researchers look forward to moving into clinical trials with humans.

The examine targeted on Syrian hamsters, discovering that the nasal vaccine offered important safety in opposition to the virus. The researchers sit up for shifting into scientific trials with people. (iStock)

“Whereas our ends in the animal mannequin are sturdy, solely scientific trials will have the ability to verify translatability to human medication,” Dr. Trimpert mentioned.

Questions stay concerning the vaccine’s security for folks with weakened immune programs and the potential threat of mixing it with totally different variants of the virus.

Advertisement

The CDC states that severely immunocompromised folks and pregnant ladies ought to keep away from reside vaccines.

Mentioned Dr. Trimpert, “We do assume there may be purpose to hope for next-generation COVID-19 vaccines that higher management virus transmission and vastly scale back illness burden.”

Health

State Department Permits Distribution of H.I.V. Medications to Resume — for Now

Published

on

State Department Permits Distribution of H.I.V. Medications to Resume — for Now

The Trump administration on Tuesday issued a waiver for lifesaving medicines and medical services, offering a reprieve for a worldwide H.I.V. treatment program that was halted last week.

The waiver, announced by Secretary of State Marco Rubio, seemed to allow for the distribution of H.I.V. medications, but whether the waiver extended to preventive drugs or other services offered by the program, the President’s Emergency Plan for AIDS Relief, was not immediately clear.

Still, PEPFAR’s future remains in jeopardy, with potential consequences for more than 20 million people — including 500,000 children — who could lose access to lifesaving medications. Without treatment, millions of people with H.I.V. in low-income countries would be at risk of full-blown AIDS and of premature death.

“We can very rapidly return to where the pandemic is exploding, like it was back in the 1980s,” said Dr. Steve Deeks, an H.I.V. expert at the University of California, San Francisco.

“This really cannot happen,” he said.

Advertisement

On Monday, the Trump administration ordered health organizations in other countries to immediately stop distributing H.I.V. medications purchased with U.S. aid. The directive stemmed from a freeze — which may become permanent — in the activities of PEPFAR, a $7.5 billion program overseen by the State Department.

Since it started in 2003, PEPFAR is estimated to have saved more than 25 million lives; more than 5.5 million children have been born free of H.I.V. who otherwise would have been infected.

In South Africa alone, PEPFAR’s shutdown would add more than a half million new H.I.V. infections and more than 600,000 related deaths over the next decade, according to one estimate.

The organization employs 270,000 doctors, nurses, pharmacists and other health workers. They had been told not to report to work or to serve patients.

PEPFAR’s end would “create instability and potentially collapse several countries’s AIDS programs that will be difficult to repair, if and when PEPFAR funding becomes available again,” said Dr. Salim Abdool Karim, an infectious disease epidemiologist at the University of KwaZulu-Natal in Durban, South Africa.

Advertisement

Dr. Abdool Karim said countries should stop relying on PEPFAR and support their own citizens, a goal that the program’s staff and partners had been working toward. But ideally that shift would happen gradually, over years during which PEPFAR would train local health workers and prepare them for the transition, he said.

“This is not a bad opportunity for countries to take greater responsibility,” he said. “But I think they can’t do it if it’s done in this kind of haphazard and unplanned way.”

Here’s what he and others expect from PEPFAR’s unexpected pause.

Every day, more than 220,000 people pick up H.I.V. medications at clinics funded by PEPFAR; the number included more than 7,400 children under 15, according to data published on Tuesday by AMFAR, The Foundation for AIDS Research.

The drugs work by suppressing H.I.V. in the body. When patients go off the drugs, the virus grabs the opportunity to rebound — and quickly. Within a week, H.I.V. levels will skyrocket from undetectable levels to more than 100,000 copies per milliliter of blood.

Advertisement

“That may be a time where you are very much at risk of passing the virus on to others,” Dr. Sallie Permar, a pediatrician and H.I.V. expert at Weill Cornell Medicine, said.

Then, the virus will start attacking a certain type of immune cell, crippling the body’s ability to fend off other infections, including tuberculosis, which frequently accompanies H.I.V. infection.

Spiking H.I.V. levels at first may cause flulike symptoms, including sore throat, swollen glands and fatigue. The immune system will likely marshal enough force to suppress the virus temporarily, but H.I.V. is adept at hiding until it finds the right opportunity to re-emerge.

When that occasion arises, “they can develop AIDS and progress,” Dr. Deeks said.

PEPFAR is best known for financing H.I.V. treatment programs, but its funds also go to drugs for prevention, outreach and testing, and to support for orphans and women experiencing gender-based violence.

Advertisement

The loss of resources for each of these efforts will derail the fight against AIDS, said Dr. Glenda Gray, a pediatric H.I.V. expert at Wits University in South Africa.

“If H.I.V. testing falls by the wayside, it’s unlikely that we will be able to even diagnose people who need to go into treatment,” she said.

If a pregnant or breastfeeding woman has H.IV. but is not tested and not treated, she may pass the virus to her child. The higher her viral load, the more likely this is to occur.

Children with H.I.V. are less likely to be diagnosed than adults, and may not be treated till the virus makes them visibly very sick. This progression can be much more rapid in children than in adults, Dr. Gray said, “and obviously, children who are untreated are likely to die.”

As people lose access to medications, they may try to spread out their supplies by alternating days or to share their pills with others. If the virus replicates in people with only partial protection, it can learn to evade those defenses and become resistant to the medications.

Advertisement

People living with the virus may then pass the resistant virus on to others.

“That becomes a big problem, because now, suddenly, our cheap first-line drugs might not work when we have to restart them on treatment,” Dr. Abdool Karim said.

A virus that is resistant to treatments will also be better at evading vaccine candidates being tested.

“Not only are we looking at more drug resistance, but we’re looking at losing whatever ability we had to make an effective vaccine,” Dr. Permar said.

More than one million Americans are living with the virus, and more than 30,000 become infected each year. If H.I.V. becomes resistant to available medications, it isn’t likely to remain in low-income countries. Americans, too, will be at risk.

Advertisement

They may also face indirect harms from ending PEPFAR. Creating huge populations of immunocompromised people may mean that other pathogens have an opportunity to spread. For example, dangerous Covid variants, including Omicron, are thought to have evolved in immunocompromised people with H.I.V.

At the same time, people worldwide have benefited from trials conducted under PEPFAR’s auspices, showing the importance of treating H.I.V. early, demonstrating that pregnant women can safely breastfeed as long as they are treated and that H.I.V. infections can be prevented with long-acting drugs.

“America has gotten an amazing amount of love around the world because of what it’s done,” Dr. Deeks said.

“From a humanitarian perspective, I can’t imagine anyone really wants to go along this pathway,” he added. “This doesn’t make any sense on any level.”

Advertisement
Continue Reading

Health

This disease kills more people than all cancers and accidents combined

Published

on

This disease kills more people than all cancers and accidents combined

Heart disease remains the top killer of Americans as risk factors continue to grow.

The latest statistics were revealed in the American Heart Association’s annual report, 2025 Heart Disease and Stroke Statistics.

The report, which was published on Jan. 27 in the AHA’s journal Circulation, revealed that cardiovascular disease kills more people than all types of cancer and accidental deaths combined.

7 BLOOD PRESSURE MISTAKES THAT COULD BE THROWING OFF YOUR READINGS

In 2022 — the most recent year for which mortality data is available — a total of 941,652 people died of heart disease-related conditions, according to the report. This was a little more than 10,000 more deaths than the prior year.

Advertisement

The age-adjusted death rate decreased slightly from last year, however.

In 2022 — the most recent year for which mortality data is available — a total of 941,652 people died of heart disease-related condition (iStock)

“Overall, we are seeing cardiovascular-related deaths leveling out compared to 2022,” said Dr. Bradley Serwer, a Maryland-based cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company that offers cardiovascular and anesthesiology services to hospitals.

“We are making some improvements in regard to improved prevalence of hyperlipidemia (high cholesterol) and lower incidence of smoking, but have lost ground in regard to diabetes, obesity and hypertension,” Serwer, who was not involved in the report, told Fox News Digital.

DIABETES, HEART DISEASE CASES SKYROCKET — AND SCIENTISTS SUGGEST A KEY REASON

Advertisement

Someone dies of heart disease every 34 seconds in the U.S., and a total of 2,500 die per day, according to Keith Churchwell, M.D., the volunteer president of the American Heart Association.

“It’s alarming to note that excess weight now costs us even more lives than smoking.”

“Those are alarming statistics to me – and they should be alarming for all of us,” Churchwell said in a press release.

“Too many people are dying from heart disease and from stroke, which remains the fifth leading cause of death.”

Risk factors

The report also detailed the prevalence of specific risk factors for heart disease.

Advertisement

More than 72% of U.S. adults have “unhealthy weight,” which is defined as a body mass index of at least 25, the report stated.

Nearly 42% of those adults meet the criteria for obesity (a body mass index of 30 or more).

Woman obesity doctor

Nearly 42% of those adults meet the criteria for obesity (a body mass index of 30 or more). (iStock)

The report also revealed that more than half of U.S. adults (57%) have type 2 diabetes or prediabetes.

“Although we have made a lot of progress against cardiovascular disease in the past few decades, there is a lot more work that remains to be done,” American Heart Association volunteer Dhruv S. Kazi, M.D., wrote in an editorial that accompanied the report.

FRIENDS, FAMILY MAY PROTECT AGAINST HEART ATTACK, STROKE AND TYPE 2 DIABETES, STUDY SUGGESTS

Advertisement

“If recent trends continue, hypertension and obesity will each affect more than 180 million U.S. adults by 2050, whereas the prevalence of diabetes will climb to more than 80 million.”

Experts predict a 300% increase cardiovascular-related healthcare costs, added Kazi, who is also head of health economics and associate director of the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center.

Heart rate monitor

“Too many people are dying from heart disease and from stroke, which remains the fifth leading cause of death.” (iStock)

The report also called out different rates of risk factors among different races and ethnic groups.

Black women were found to have the highest rate of obesity (57.9%) and Asian women had the lowest rate (14.5%).

Black women also had the highest rate of blood pressure (58.4%) and Hispanic women, at 35.3%, had the lowest rate.

Advertisement

“Just because we are seeing improvements in smoking and high cholesterol doesn’t mean we can back off.”

“We are also seeing a rise in obesity in our youth, with as many as 40% having unhealthy weight,” Serwer warned. 

“This trend continues into adulthood, when we see nearly 60% of adults having unhealthy weight.”

      

Excess weight is a contributing factor in as many as 1,300 additional deaths per day in the U.S., or nearly 500,000 per year, according to the report.

Advertisement

“It lowers life expectancy by as much as 2.4 years compared to a healthy weight,” said American Heart Association volunteer Latha P. Palaniappan, M.D., a professor of cardiovascular medicine at Stanford University in Palo Alto, California. 

Man holding chest

“Any medical or clinical therapies that can treat the risk factors that contribute to cardiovascular disease are essential.” (iStock)

“It’s alarming to note that excess weight now costs us even more lives than smoking – as smoking rates have actually fallen in recent years. Being overweight is the new smoking when it comes to health threats.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

One positive finding in the report is that rates of high cholesterol have dropped, which is attributed to improved dietary and lifestyle factors, availability of medications and “better clinical control.”

“Recent clinical research has identified a number of new medication therapies to address the growing burden of obesity, as well, and we look forward to learning more about those advances as the body of science builds,” Churchwell noted.

Advertisement

What needs to change?

The researchers called for interventions to help reduce heart disease risk factors.

“Any medical or clinical therapies that can treat the risk factors that contribute to CVD are essential,” Churchwell wrote. “…We need to stop these risk factors in their tracks, keep people healthy throughout their lifespan.”

Serwer agreed that the best way to combat this top killer is to aggressively attack the risk factors. 

“Just because we are seeing improvements in smoking and high cholesterol doesn’t mean we can back off,” he said.

For more Health articles, visit www.foxnews.com/health

Advertisement

“We need to continue to aggressively attack tobacco use and treat hyperlipidemia while increasing efforts to treat obesity, high blood pressure and diabetes.”

Continue Reading

Health

Caroline Kennedy Calls RFK Jr. a ‘Predator’ in Letter to Senators

Published

on

Caroline Kennedy Calls RFK Jr. a ‘Predator’ in Letter to Senators

Caroline Kennedy wrote a scathing letter to key senators on Tuesday, calling her cousin, Robert F. Kennedy Jr., a “predator” addicted to attention from airing dangerous views on vaccinations and someone who is unfit to be the nation’s health secretary.

She urged lawmakers, who will be questioning Mr. Kennedy at his confirmation hearings Wednesday and Thursday, to reject his nomination. She cited his lack of experience, misinformed views on vaccines and personal attributes. In the letter, she described how he led other family members “down the path of drug addiction.”

“His basement, his garage, and his dorm room were the centers of the action where drugs were available, and he enjoyed showing off how he put baby chickens and mice in the blender to feed his hawks,” Ms. Kennedy wrote. “It was often a perverse scene of despair and violence.”

Her letter was first reported in The Washington Post.

Ms. Kennedy expressed particular outrage over the new disclosures in his ethics agreement filed with the Senate, which she described as outlining how his “crusade against vaccination has benefited him in other ways.”

Advertisement

She cited Mr. Kennedy’s decision to keep a financial stake in litigation against Merck, which makes a key vaccine against the human papillomavirus (HPV) that is administered to protect against cervical cancer.

“In other words, he is willing to enrich himself by denying access to a vaccine that can prevent almost all forms of cervical cancer and which has been safely administered to millions of boys and girls,” Ms. Kennedy wrote.

As President Joseph R. Biden Jr.’s ambassador to Australia, Ms. Kennedy was actively involved in promoting the HPV vaccine, which has put Australia on a path to eliminate cervical cancer. She was instrumental in persuading Mr. Biden to expand his “cancer moonshot” initiative to the Indo-Pacific region.

In her role as ambassador, Ms. Kennedy said, she was reluctant to make public comments against Mr. Kennedy, who launched his presidential campaign in 2023 as a primary challenger to Mr. Biden before running as an independent candidate. When Mr. Kennedy dropped his presidential bid, he endorsed Mr. Trump, who, after winning the election, named Mr. Kennedy as his choice for health secretary.

After that, she broke with her cousin, saying his views about vaccination were dangerous.

Advertisement

Her letter painted Mr. Kennedy as a charismatic figure, “willing to take risks and break the rules,” and able to attract others through the strength of his magnetic personality. Then she traced a tragic history of Mr. Kennedy’s influence over other family members.

“But siblings and cousins who Bobby encouraged down the path of substance abuse suffered addiction, illness and death,” she wrote, “while Bobby has gone on to misrepresent, lie and cheat his way through life.”

Mr. Kennedy’s younger brother David died in Palm Beach County in May of 1984 of “multiple ingestion” of three drugs found in his body fluids, authorities said at the time.

Other relatives have also spoken out against Mr. Kennedy, including his brother Joseph Kennedy II and his sister Kerry Kennedy, who described his comments on race and vaccines as “deplorable and untruthful.”

On Tuesday, Jack Schlossberg, Ms. Kennedy’s son, who has also been critical of Mr. Kennedy, posted a video on social media of his mother reading the letter she had written.

Advertisement

“I’m so proud of my courageous mother, who’s lived a life of dignity, integrity and service,” Mr. Schlossberg wrote.

Ms. Kennedy, in the letter sent Tuesday, gave her cousin credit for overcoming his drug addiction, which Mr. Kennedy has discussed extensively. By his own account, Mr. Kennedy became addicted to heroin when he was 14, in 1968, as he struggled to cope with the assassination of his father. In 1984, he pleaded guilty to a felony charge of possessing heroin, and entered treatment.

But Ms. Kennedy was harsh in criticism of her cousin’s advocacy against vaccines, describing it as part of an addiction to attention and power.

“Bobby preys on the desperation of parents of sick children — vaccinating his own children while building a following by hypocritically discouraging other parents from vaccinating theirs,” she wrote.

Ms. Kennedy also highlighted “the conspiratorial half-truths he has told about vaccines,” in connection with the 2019 measles outbreak in Samoa, which she said “cost lives.”

Advertisement

The letter was addressed to senators who lead the committees that will be reviewing his nomination this week, including Mike Crapo, a Republican from Idaho; Ron Wyden, a Democrat from Oregon; Bill Cassidy, a Republican of Louisiana and Bernie Sanders, an Independent of Vermont.

She noted that the family is close and that speaking out was difficult. Still, she faulted her cousin for using the family’s legacy of tragedy for political gain. Mr. Kennedy’s father, Robert F. Kennedy, was assassinated during a campaign for president in 1968. Her father and his uncle, President John F. Kennedy, was fatally shot in Dallas in 1963.

Robert F. Kennedy Jr. “distorted President Kennedy’s legacy to advance his own failed presidential campaign — and then groveled to Donald Trump for a job,” the letter said. “Bobby continues to grandstand off my father’s assassination, and that of his own father.”

She suggested that her father John F. Kennedy, her uncle Robert F. Kennedy and another uncle, the long-serving lawmaker Ted Kennedy, “would be disgusted.”

She closed the letter with a plea for the senators to reject her cousin’s nomination on behalf of the doctors, nurses, scientists and caregivers who fuel the American health care system.

Advertisement

“They deserve a secretary committed to advancing cutting-edge medicine to save lives, not rejecting the advances we have already made,” Ms. Kennedy wrote. “They deserve a stable, moral and ethical person at the helm of this crucial agency. They deserve better than Bobby Kennedy — and so do the rest of us.”

Continue Reading
Advertisement

Trending